Program areas at NASTAD
Syndemic approachesprevention: Nastad's hiv prevention and surveillance activities are primarily funded through a cdc cooperative agreement to conduct capacity building/technical assistance (ta) activities and communication in support of State and local hiv prevention programs funded for phase 1 of ending the hiv epidemic (ehe) initiative. Additionally, Nastad has received funding from cdc through cstlts to development a learning community regarding hiv cluster detection and response. On september 30, 2022, Nastad received funding from cdc dhp for supplemental funds to expanded on Nastad's ehe phase i implementation activities. On september 30, 2022, Nastad was funded through a subaward from emory university for a cdc National hiv self-testing project called together take me home.viral hepatitis: through a cooperative agreement with funding from the cdc's division of viral hepatitis (through the cstlts funding mechanism) Nastad has a (virtual) technical assistance (ta) center (heptac) to support health department hepatitis programs with the prevention, surveillance, and laboratory activities. The program includes supporting health department hepatitis prevention and surveillance programs with tailored technical assistance and other modalities including virtual learning communities. Additionally, Nastad is funded for another cooperative agreement with cdc's division of viral hepatitis: National viral hepatitis education, awareness, and capacity building for communities and providers (hepnet). Finally, Nastad's hepatitis program also includes participation and leadership in the National viral hepatitis roundtable and promotion of federal programs that address hepatitis a (hav) and hepatitis b (hbv) vaccine for high-risk adults, prevention of hcv, chronic hbv and hcv and hiv hcv co infection. This program is supported by both the membership and corporate donors.drug user health: Nastad has a cooperative with cdc division of viral hepatitis (dvh) for the National harm reduction technical assistance center. In addition, supporting the provision of ta to syringe services programs (ssps) and other harm reduction providers, it included a demonstration project through which Nastad awarded funds to support ssps with providing access to medication assessment treatment and other services. Nastad also has cooperative agreements with cdc through cstlts focused on expanding ssp capacity to respond to covid 19 and for an expansion of the of National harm reduction technical assistance center to include coordination of samhsa-funded ta providers. Finally, on september 30, 2022 Nastad was awarded a cooperative with cdc's dvh for strengthening syringe services programs (ssps) through which Nastad will provide direct funding to ssps throughout the u.s.
Organizational excellencecba: Nastad has a cooperative agreement with cdc's division of hiv prevention (dhp) to provide technical assistance to health departments and cdc-directly funded community based organizations (cbos) on integrated hiv prevention strategies. National hiv and hepatitis technical assistance meeting: Nastad convenes a technical assistance meeting each year for hiv prevention, care including adap coordinators, hepatitis, and drug user health staff. It is supported through corporate contributions specifically for this purpose.annual meeting: Nastad convenes an annual meeting of the general membership each spring, supported by the membership and corporate donors. This program includes all activities in support of the annual meeting that are not directly supported by other programs.
Strengthening public health systemshealth care access: Nastad was awarded the next iteration of a five-year cooperative agreement with health resources and services administration (hrsa) to provide technical assistance (ta) for Aids drug assistance programs (adap) and ryan white part b programs. Program activities include a focus on adap clinical quality, as well as ta to adaps on various issues including implementation of the affordable care act (aca), insurance purchasing, integrated planning, financial forecasting, implementing quality measures and new data collection activities, developing, and disseminating various materials, and implementing and monitoring drug pricing agreements. Nastad has an ongoing project supported by corporate donors to monitor and assess the status of State adaps authorized under part b of the ryan white program. In addition to producing the National adap monitoring project annual report, the program provides ta to State adaps regarding various programmatic and fiscal issues. Nastad also convenes and supports the work of an adap crisis task force, made up of State Aids directors and adap coordinators working on behalf of all State hiv/aids programs to improve the fiscal status of State adap programs. This program is supported by Nastad's membership. Health systems integration: Nastad had two cooperative agreements with health resources and services administration (hrsa). One is service as the systems coordination provider (scp) for hrsa's ending the hiv epidemic (ehe) initiative. The second cooperative agreement for a special projects of National significance (spns) initiative: building capacity to improve collecting and reporting viral suppression data to the medicaid adult core set. Finally, Nastad's health systems integration is funded through a subaward from jsi to support a hrsa project focused on the integration and service coordination between the ryan white hiv/aids program and opiate use disorder (oud).
Health equity: Nastad concluded a cooperative agreement with health resources and services administration (hrsa) special projects of National significance (spns) to develop resources including a compendium of manuals that provide implementation strategies for evidence informed interventions to link persons living with hiv to care. Additionally, Nastad receives funding for several non-federal sources to support its minority leadership program (mlp).
Policy and legislative affairs: Nastad's policy and legislative affairs program translates State concerns regarding hiv/aids and hepatitis care, treatment, and prevention programs into sound federal policy. Staff members develop strategies to increase and affect the direction of funding for State public health programs related to access to prevention and care programs for persons at risk for and infected with hiv and hepatitis. Nastad also plays a key role in shaping hiv and hepatitis policy through its leadership in numerous federal coalitions, including the federal Aids policy partnership including its subgroups of the healthcare access work group, ryan white work group, prevention action committee and the Aids budget and appropriations committee; hepatitis appropriations partnership; and the National viral hepatitis roundtable. This program is supported by both the membership and corporate donors. This policy work includes a specific focus on affordable care act (aca) implementation policies working primarily through coalitions listed above as well as research activities related to the aca.